Advancing Standardization in Fragile X Syndrome Molecular Diagnosis: A Dual-Structured and Scoping Review
Open Access
Abstract
Background: Fragile X syndrome (FXS) requires molecular confirmation, yet diagnostic workflows vary in their capacity to characterize expansions and connect diagnosis with subsequent care. This review evaluated alignment between current recommendations and published diagnostic practice. Methods: We combined a structured review of recommendations for FMR1 molecular diagnosis, complementary testing, genetic counseling, and family testing with a scoping review of peer-reviewed primary studies reporting FMR1 diagnostic or screening workflows relevant to pediatric FXS. PubMed/MEDLINE, Embase, and Scopus were searched without date restrictions. Thirty-four studies were included, with design-specific risk-of-bias assessment and exploratory exact analyses of factors associated with post-initial FMR1 testing. Results: Molecular or genomic testing was reported in all 34 studies, but workflows ranged from conventional PCR and Southern blot to TP-PCR, methylation-sensitive assays, and sequencing-based approaches. Post-initial FMR1 testing was reported in 22/34 studies (64.7%), with positive-result follow-up documented in 19/34 (55.9%) and follow-up of inconclusive or initially negative results in 14/34 (41.2%). FMR1 sequencing was uncommon (3/34, 8.8%). Genetic counseling was addressed in 32/34 studies (94.1%), but documented as delivered in only 9/34 (26.5%); family evaluation and multidisciplinary management were also inconsistently reported. Conclusions: Published evidence broadly supports molecular FMR1 testing but shows variability in molecular characterization and downstream care. Standardization should prioritize analytically appropriate workflows, additional testing when required by the initial result or assay limitations, and stronger integration of molecular diagnosis with genetic counseling, family evaluation, and multidisciplinary management.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
This publication has 79 references indexed in Scilit:
- Standardization of capillary electrophoresis for diagnosis of fragile X syndrome in the Brazilian public health systemElectrophoresis, 2016
- Clinical audit of genetic testing and referral patterns for fragile X and associated conditionsAmerican Journal of Medical Genetics Part A, 2016
- Newborn Screening for Fragile X SyndromeJAMA Neurology, 2014
- Frequency of FMR1 gene mutation and CGG repeat polymorphism in intellectually disabled children in PakistanAmerican Journal of Medical Genetics Part A, 2014
- Newborn screening and cascade testing for FMR1 mutationsAmerican Journal of Medical Genetics Part A, 2012
- Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: A case report and review of the literatureAmerican Journal of Medical Genetics Part A, 2008
- Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardationAmerican Journal of Medical Genetics Part A, 2006
- Pilot study for the neonatal screening of fragile X syndromePrenatal Diagnosis, 2002
- Physical characteristics of young boys with fragile X syndrome: Reasons for difficulties in making a diagnosis in young malesAmerican Journal of Medical Genetics, 2000
- Mosaicism in fragile X affected malesAmerican Journal of Medical Genetics, 1994